Source link : https://www.newshealth.biz/health-news/bleeding-risk-clarified-in-stroke-patients-receiving-tpa/
Patients with ischemic stroke on antiplatelet therapy are at a significantly higher risk for symptomatic intracranial hemorrhage (sICH) following thrombolysis, but the absolute increased risk is small, results of a new study showed. The findings should be reassuring to clinicians who might hesitate to prescribe thrombolysis therapy such as IV tissue plasminogen activator (IV-tPA) to […]
Author : News Health
Publish date : 2024-05-23 09:32:12
Copyright for syndicated content belongs to the linked Source.